310 related articles for article (PubMed ID: 15341595)
61. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.
Wu CC; Kuo SC; Lee FY; Teng CM
Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886
[TBL] [Abstract][Full Text] [Related]
62. Soluble guanylyl cyclase is localised in the acinar cells and participates in amylase secretion in rat parotid gland.
Shimomura H; Tanaka S; Komine N; Shimooka S; Imai A; Nashida T
Arch Oral Biol; 2004 Sep; 49(9):691-6. PubMed ID: 15275856
[TBL] [Abstract][Full Text] [Related]
63. Protective effects of YC-1 against glutamate induced PC12 cell apoptosis.
Yang X; Wang Y; Luo J; Liu S; Yang Z
Cell Mol Neurobiol; 2011 Mar; 31(2):303-11. PubMed ID: 21063768
[TBL] [Abstract][Full Text] [Related]
64. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
65. Modulation of human monocyte-derived dendritic cells maturation by a soluble guanylate cyclase activator, YC-1, in a cyclic nucleotide independent manner.
Tsai IF; Lin CY; Huang CT; Lin YC; Yang CM; Lin YC; Liao CH
Int Immunopharmacol; 2007 Oct; 7(10):1299-310. PubMed ID: 17673145
[TBL] [Abstract][Full Text] [Related]
66. The nitric oxide/cyclic GMP messenger system in olfactory pathways of the locust brain.
Bicker G; Schmachtenberg O; De Vente J
Eur J Neurosci; 1996 Dec; 8(12):2635-43. PubMed ID: 8996813
[TBL] [Abstract][Full Text] [Related]
67. G-substrate: the cerebellum and beyond.
Endo S
Prog Mol Biol Transl Sci; 2012; 106():381-416. PubMed ID: 22340725
[TBL] [Abstract][Full Text] [Related]
68. NO-independent, haem-dependent soluble guanylate cyclase stimulators.
Stasch JP; Hobbs AJ
Handb Exp Pharmacol; 2009; (191):277-308. PubMed ID: 19089334
[TBL] [Abstract][Full Text] [Related]
69. Activation of soluble guanylyl cyclase inhibits estradiol production and cyclic AMP accumulation from cultured rat granulosa cells.
Tafoya MA; Chen JY; Stewart RL; Lapolt PS
Fertil Steril; 2004 Oct; 82 Suppl 3():1154-9. PubMed ID: 15474089
[TBL] [Abstract][Full Text] [Related]
70. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
[TBL] [Abstract][Full Text] [Related]
71. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
72. On the activation of soluble guanylyl cyclase by nitric oxide.
Bellamy TC; Wood J; Garthwaite J
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):507-10. PubMed ID: 11752394
[TBL] [Abstract][Full Text] [Related]
73. Localization of mRNAs encoding alpha and beta subunits of soluble guanylyl cyclase in the brain of rainbow trout: comparison with the distribution of neuronal nitric oxide synthase.
Ando H; Shi Q; Kusakabe T; Ohya T; Suzuki N; Urano A
Brain Res; 2004 Jul; 1013(1):13-29. PubMed ID: 15196964
[TBL] [Abstract][Full Text] [Related]
74. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium.
Cetin A; Kaya T; Demirkoprulu N; Karadas B; Duran B; Cetin M
J Pharmacol Sci; 2004 Jan; 94(1):19-24. PubMed ID: 14745113
[TBL] [Abstract][Full Text] [Related]
75. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
Bellingham M; Evans TJ
Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
[TBL] [Abstract][Full Text] [Related]
76. Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
Ehsan A; Sommer F; Schmidt A; Klotz T; Koslowski J; Niggemann S; Jacobs G; Engelmann U; Addicks K; Bloch W
Cancer; 2002 Dec; 95(11):2293-301. PubMed ID: 12436434
[TBL] [Abstract][Full Text] [Related]
77. BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase.
Koglin M; Stasch JP; Behrends S
Biochem Biophys Res Commun; 2002 Apr; 292(4):1057-62. PubMed ID: 11944922
[TBL] [Abstract][Full Text] [Related]
78. Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2001 Jun; 15(6):1010-22. PubMed ID: 11376118
[TBL] [Abstract][Full Text] [Related]
79. Regulation of nitric oxide and soluble guanylyl cyclase.
Krumenacker JS; Hanafy KA; Murad F
Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
[TBL] [Abstract][Full Text] [Related]
80. Expression of soluble guanylyl cyclase in rat cerebral cortex during postnatal development.
Ding JD; Burette A; Weinberg RJ
J Comp Neurol; 2005 May; 485(3):255-65. PubMed ID: 15791641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]